An electrocardiogram pattern characterized by a wide QRS complex with a specific morphological pattern defines left bundle branch block, or LBBB. This conduction abnormality alters the sequence of ventricular activation and is commonly associated with underlying structural heart disease or fibrosis.
On surface ECG, LBBB typically produces a broad R wave in lateral leads and a deep S wave in right precordial leads, with secondary ST-T changes that may mimic ischemia. Clinicians rely on standardized criteria to confirm the diagnosis and differentiate it from other wide complex rhythms.
| Feature | LBBB ECG Characteristics | Clinical Implications | Key Diagnostic Considerations |
|---|---|---|---|
| QRS Duration | ≥ 120 milliseconds | Indicates delayed ventricular depolarization | Requires ruling out other wide complex patterns |
| RS Complex | No q wave in left precordial leads; broad monophasic R in I, aVL, V5, V6 | Reflects left ventricular activation delay | May obscure underlying infarction clues |
| ST-T Changes | Direction opposite to the terminal deflection | May simulate myocardial ischemia | ECG exercise stress testing less reliable |
| Underlying Causes | Ischemic heart disease, hypertension, aortic valve disease, cardiomyopathy | Guides evaluation and management | Age-related fibrosis and conduction system disease contribute |
ECG Diagnostic Criteria for LBBB
Major Criteria
The major ECG diagnostic criteria for LBBB include a QRS duration of 120 milliseconds or longer, a broad monophasic R wave in leads I, aVL, V5, and V6, and the absence of a pathologic Q wave in left precordial leads. Additionally, the ST segment and T wave typically deflect opposite to the terminal QRS vector.
Supporting Features
Supportive features include unusually wide notched R waves in left-sided leads, delayed activation patterns seen in vectorcardiography, and concordance of the frontal plane axis with the QRS morphology. Pseudo–left axis deviation may occur if septal involvement modifies initial forces.
Differential Diagnosis and Mimics
Conditions That Can Resemble LBBB
Ventricular paced rhythm, left ventricular hypertrophy with repolarization abnormalities, and certain preexcitation syndromes may mimic LBBB. Acute myocardial infarction with conduction disease and electrolyte disturbances also require consideration in specific clinical contexts.
Clinical Management and Prognosis
Evaluation and Treatment
Assessment often includes echocardiography, cardiac MRI, and ambulatory monitoring to evaluate underlying structural disease. Management focuses on optimizing conditions such as hypertension, coronary artery disease, and valvular abnormalities, while pacing is reserved for cases with advanced conduction system disease and symptoms.
Key Takeaways and Recommendations
- Recognize LBBB by QRS ≥ 120 ms with characteristic morphology in standard surface leads.
- Distinguish pseudo–left axis deviation and mimics such as paced rhythm or hypertrophy.
- Evaluate for reversible causes and structural heart disease before attributing symptoms to LBBB.
- Use imaging and advanced testing when ischemia or heart failure is suspected.
- Follow individualized management plans that address conduction disease and comorbidities.
FAQ
Reader questions
Can LBBB alone cause symptoms like dizziness or fatigue?
LBBB is often asymptomatic; symptoms usually arise from the underlying structural heart disease or associated bradyarrhythmias rather than the conduction abnormality alone.
Does LBBB affect exercise tolerance or risk during physical activity?
Exercise tolerance depends on overall cardiac function; significant LBBB with reduced ejection fraction may limit capacity and warrant careful evaluation before intensive training.
How does LBBB change the interpretation of stress tests for ischemia?
Baseline LBBB limits the usefulness of conventional ECG stress testing, often requiring pharmacologic imaging or cardiac magnetic resonance to accurately detect inducible ischemia.
Are there specific medications to treat LBBB itself?
No drug directly eliminates LBBB; management targets modifiable risk factors, underlying structural disease, and pacing when conduction disturbances lead to bradyarrhythmia symptoms.